Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?
Kyverna Therapeutics Ownership Summary
Kyverna Therapeutics is owned by 57.65% institutional investors, 6.83% insiders, and 35.52% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 10.47% of KYTX shares. MEDICAL BioHealth EUR Acc is the top mutual fund, with 2.85% of its assets in Kyverna Therapeutics shares.
KYTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kyverna Therapeutics | 57.65% | 6.83% | 35.52% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 10.47% | $27.14M |
| Gilead sciences | 4.13M | 6.78% | $28.06M |
| Bain capital life sciences investors | 3.11M | 6.60% | $26.84M |
| Aigh capital management | 3.65M | 5.99% | $24.82M |
| Blackrock funding, inc. /de | 3.24M | 5.32% | $22.02M |
| Deerfield management company, l.p. (series c) | 2.00M | 4.24% | $17.26M |
| Vanguard group | 1.78M | 4.10% | $16.74M |
| Vanguard capital management | 2.01M | 3.30% | $13.68M |
| Price t rowe associates inc /md/ | 1.56M | 3.30% | $13.42M |
| Balyasny asset management | 1.13M | 2.39% | $9.71M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 92.41% | $27.14M |
| Caxton | 12.35K | 3.02% | $83.96K |
| Propel bio management | 700.60K | 2.53% | $4.76M |
| Aigh capital management | 3.65M | 2.50% | $24.82M |
| Bain capital life sciences investors | 3.11M | 2.42% | $26.84M |
| Gilead sciences | 4.13M | 1.92% | $28.06M |
| Catalio capital management, lp | 586.91K | 0.65% | $3.52M |
| Mbb public markets i | 614.48K | 0.63% | $5.30M |
| Insight group | 989.05K | 0.60% | $8.54M |
| Nano cap new millennium growth fund l p | 90.00K | 0.44% | $612.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aigh capital management | 3.65M | 2.50% | 854.20K |
| Vanguard group | 1.78M | 0.00% | 458.63K |
| Fmr | 538.38K | 0.00% | 442.33K |
| Millennium management | 1.01M | 0.00% | 412.14K |
| Susquehanna group, llp | 577.60K | 0.00% | 338.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Novo | - | - | -1.85M |
| Adage capital partners gp | 500.00K | 0.01% | -1.17M |
| Alyeska investment group | - | - | -600.00K |
| Rfg advisory | - | - | -445.20K |
| Morgan stanley | 552.25K | 0.00% | -430.06K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 114.84K | 0.02% | 114.84K | $991.08K |
| Franklin resources | 78.00K | 0.00% | 78.00K | $402.46K |
| Man group | 53.54K | 0.00% | 53.54K | $462.08K |
| Exoduspoint capital management, lp | 49.01K | 0.00% | 49.01K | $422.96K |
| Act capital partners | 40.00K | 0.18% | 40.00K | $272.00K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -16.00 |
| Sbi securities | -22.00 |
| Larson financial group | -40.00 |
| Rothschild investment | -50.00 |
| Advisory services network | -86.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 124 | -3.13% | 35,109,425 | -7.42% | 57 | 1.49% | 74 | 4.23% | 24 | -7.69% |
| Jun 30, 2026 | 128 | 10.34% | 37,929,570 | 8.92% | 62 | 1.88% | 71 | 22.41% | 26 | -27.78% |
| Mar 31, 2026 | 53 | -50.00% | 12,294,874 | -64.00% | 26 | 0.42% | 30 | -53.85% | 12 | -45.45% |
| Dec 31, 2025 | 62 | -21.52% | 14,501,210 | -36.11% | 33 | 1.21% | 39 | 21.88% | 12 | -53.85% |
| Sep 30, 2025 | 76 | 1.33% | 22,548,873 | 0.47% | 52 | 1.94% | 30 | -26.83% | 26 | 8.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| MEDICAL BioHealth EUR Acc | 1.76M | 2.85% | 373.00 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.57M | 2.54% | 167.76K |
| Vanguard Total Stock Mkt Idx Inv | 1.40M | 2.31% | 56.30K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.40M | 2.31% | 56.30K |
| iShares Russell 2000 ETF | 1.08M | 1.74% | - |
| T. Rowe Price Health Sciences | 856.80K | 1.39% | - |
| Fidelity Enhanced Small Cap Core ETF | 507.05K | 0.82% | 1.36K |
| Fidelity Small Cap Index | 459.63K | 0.74% | 1.28K |
| Vanguard Institutional Extnd Mkt Idx Tr | 436.88K | 0.71% | -11.26K |
| apo Medical Opportunities R | 368.61K | 0.60% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 18, 2025 | SEIDENBERG BETH C | - | Buy | $1000.00K |
| Dec 18, 2025 | Westlake BioPartners Opportunity Fund I, L.P. | - | Buy | $1000.00K |
| Dec 15, 2025 | Walker Karen Marie | Chief Technology Officer | Sell | $292.78K |
| Feb 12, 2024 | GILEAD SCIENCES, INC. | - | Buy | $20.02M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 2 | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
KYTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools